Advances in the Research of Cardiovascular Genetics

Dear Colleagues,

Cardiovascular disease (CVD) is a general term that describes a range of conditions that affect heart and blood vessels. Globally, CVDs are among the leading causes of death and disability. In the past decade, much scientific effort has focused on developing better knowledge of the pathophysiology of CVDs; however, important gaps remain in our understanding of the genetic basis of these diseases.

The goal of this Special Issue is to present state-of-the-art cardiovascular genetics research based on in vivo, in vitro, and in silico models, in order to discover the determinants of disease progression and potential strategies for prevention, early diagnosis, and treatment. This issue will also provide insights into future directions in the development of more personalized medicine.

We encourage researchers to contribute original research articles, as well as reviews, on all aspects of cardiovascular genetics; these include, but are not limited to: EWAS-GWAS, WES-WGS, polygenic risk scores, mitochondrial DNA, telomere analysis, epigenetics, multi-omics approaches, CRISPR-Cas gene editing, and gene/cell therapy.

Dr. Martina Calore
Dr. Marzia De Bortoli
Dr. Elisa Di Pasquale
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• genetics
• epigenetics
• next-generation sequencing
• genome editing
• gene therapy
• disease modeling
• cell therapy